ELDORADO
ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma
Arms / Cohorts
Experimental:Daratumumab with lenalidomide, bortezomib, and dexamethasone (dara-RVd lite)
Not yet accepting
Experimental:Elranatamab with lenalidomide, bortezomib, and dexamethasone (elra-RVd lite)
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.